Cargando…
Gene Expression Profile of Dendritic Cell-Tumor Cell Hybrids Determined by Microarrays and Its Implications for Cancer Immunotherapy
Background. Dendritic cell- (DC-) tumor fusion cells stimulate effective in vivo antitumor responses. However, therapeutic approaches are dependent upon the coadministration of exogenous 3rd signals. The purpose of this study was to determine the mechanisms for inadequate 3rd signaling by electrofus...
Autores principales: | Dannull, Jens, Tan, Chunrui, Farrell, Christine, Wang, Cynthia, Pruitt, Scott, Nair, Smita K., Lee, Walter T. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4641191/ https://www.ncbi.nlm.nih.gov/pubmed/26605345 http://dx.doi.org/10.1155/2015/789136 |
Ejemplares similares
-
Impact of anti-CD25 monoclonal antibody on dendritic cell-tumor fusion vaccine efficacy in a murine melanoma model
por: Tan, Chunrui, et al.
Publicado: (2013) -
High-throughput identification and dendritic cell-based functional validation of MHC class I-restricted Mycobacterium tuberculosis epitopes
por: Nair, Smita K., et al.
Publicado: (2014) -
Dendritic cell hybrid nanovaccine for mild heat inspired cancer immunotherapy
por: Shi, Chen, et al.
Publicado: (2023) -
Correction: Dendritic cell hybrid nanovaccine for mild heat inspired cancer immunotherapy
por: Shi, Chen, et al.
Publicado: (2023) -
Natural Killer–Dendritic Cell Interactions in Liver Cancer: Implications for Immunotherapy
por: Cazzetta, Valentina, et al.
Publicado: (2021)